WED 14 APR 3:00 PM BST -

WED 14 APR 4:00 PM BST

The Patient Journey in CAR-T Webinar in Partnership with Covance

Hosted by: Covance

Treating cancer patients with cell and gene therapy products, especially autologous products, is a process that must account for the needs and perspectives of patients, caregivers and treating physicians. Each of these stakeholders faces their own unique concerns and challenges, for example, with decision making, enrolling, scheduling, post-infusion management and long-term follow up.

Join this educational webinar to learn about the experiences of evaluating CAR T treatment options and the role of a multi-disciplinary team in enhancing a patient-centric approach. The discussion will examine critical considerations for nurses and physicians as well as the logistical hurdles that patients and caregivers face.

The speakers will also cover the additional challenges of ensuring trial continuity, pretreatment management and patient safety during the COVID-19 era as it relates to decentralized clinical trial solutions, such as telemedicine, home nursing and eConsent, which can help minimize risks in these complex trials and help support patients in their journey.

This webinar is part of a scientific series Covance is offering focused on trends, opportunities and challenges associated with current and future applications in Oncology. Learn more and register for upcoming webinars on topics such as adoptive T-cell therapies, biomarker technologies for the detection of rare cancer driver mutations and novel targeted therapies, and more.

Representing TrakCel

Debra Susarchick, Chief Product Officer and Head, Marketing, Trakcel

Debra started her career in the Pharmaceutical industry in 1996, when she joined Merck & Co., Inc., where she held positions on both Information Technology and Commercial teams. She then went to Celgene Corporation, where her focus was on Commercial innovation, enabling key transformational initiatives for the US Commercial Hematology/Oncology team. She then went to Kite Pharma where she directed the design, development and global launch of the Kite Konnect™ customer engagement platform, which supported the global launch of YESCARTA®, the first CAR-T for adult aggressive lymphoma. With Gilead, she holds two patents for the digitization of Chain of Identity and Chain of Custody. Building on her success at Kite, Debra then joined TrakCel at the end of 2019 and has successfully led TrakCel’s product transformation with the launch of OCELLOS by TrakCel, the first cellular orchestration platform available on the Salesforce App Exchange.

To register your interest for the event click the book now link to register via Covance.

Tour our tomorrow, today